FY21 Result: A good result for the retailer with like for like sales growth of 23% over the year booking an underlying NPAT of $306.8m, about a ~2% beat to expectations and up 107% on FY20 . That said, lockdowns are currently biting with trading to start the 1st 7 weeks of the year showing signs of slowing growth hence the muted share price reaction. Shares are trading marginally lower at time of writing, down -0.61% to $13.05
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Performance update for March, stocks that drove returns & our current positioning
Close
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Close
Market Matters Research Lead Shawn Hickman with David Koch
Close
MM is neutral SUL at best around $13
Add To Hit List
Related Q&A
Retail Stocks – Are they a buy yet?
Thoughts on SIQ & SUL please
Can I have your view on SUL and HLS please?
Does MM like currently PMV, LOV &/or SUL?
MM’s thoughts on LOV, PMV and SUL please
Thoughts on CAJ & SUL please
What’s MM’s sell level for Super Retail Group (SUL)
What are thoughts on Calix, IGL, SIQ and SUL?
Capital Health (CAJ) + Super Retail (SUL)
Relevant suggested news and content from the site
Video
WATCH
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Podcast
LISTEN
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Daily Podcast Direct from the Desk
Video
WATCH
Market Matters Research Lead Shawn Hickman with David Koch
Recorded Monday 25th March
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.